WebMD Seen Getting More Mobile Ads From Drug Firms

By | December 2, 2013

Scalper1 News

Health-information website WebMD (WBMD) received a stock rating upgrade Monday on its improving mobile advertising prospects, but the Internet sector overall got a downgrade. Goldman Sachs analyst Health Terry raised his rating on WebMD to neutral from sell “based on recent signs that the company is beginning to monetize its mobile inventory with higher-value Pharma advertisers,” he wrote in a research note. But he downgraded several other Scalper1 News

Scalper1 News